Doma Biopharmaceutical（suzhou）co., Ltd.

This early-phase trial tests an experimental drug, DM005, in about 136 people with advanced solid tumors (like lung, head and neck, or other cancers) that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see how wel…